SCHEMBL2652214

SCHEMBL2652214

O=C(O)CCNC(=O)c1ccc(SCC(c2ccc(-c3ccc(C(F)(F)F)cc3)nc2)C2CCCCC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GCGR P47871 10/20 0.50
GIPR P48546 2/20 0.50
GLP1R P43220 1/20 0.50
GCG P01275 10/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2652086 0.92 GCGR (0.42) GCGRGIPRGLP1RGCG
SCHEMBL2653111 0.85 PPARD (0.40)
SCHEMBL2274070 0.83 GCGR (0.49) GCGRGIPRGLP1RGCG
SCHEMBL2274074 0.83 GCGR (0.49) GCGRGIPRGLP1RGCG
SCHEMBL2276673 0.83 GCGR (0.49) GCGRGIPRGLP1RGCG
SCHEMBL14184604 0.78 GCGR (0.51) GCGRGIPRGLP1RGCG
SCHEMBL2270697 0.78 GCGR (0.54) GCGRGIPRGLP1RGCG
SCHEMBL2270701 0.78 GCGR (0.54) GCGRGIPRGLP1RGCG
SCHEMBL2272009 0.78 GCGR (0.54) GCGRGIPRGLP1RGCG
SCHEMBL2268254 0.77 GCGR (0.54) GCGRGIPRGLP1RGCG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758859-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 EP claimed
WO-2005118542-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-15 WO claimed
EP-1758859-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 EP disclosed
WO-2005118542-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-15 WO disclosed